Four Brits develop Guillain-Barré syndrome just days after having AstraZeneca’s Covid jab

Share this:

Four British men have developed a potentially life-threatening condition just days after having AstraZeneca‘s Covid vaccine.

 

The recipients developed Guillain-Barré syndrome, which can cause paralysis and leave patients in crippling pain.

All four cases were spotted in the Nottingham area, where around 700,000 people have had the British firm’s coronavirus jab.

British health chiefs have yet to offer a public breakdown of how many cases of the syndrome have been spotted in vaccine recipients across the entire country.

But a similar link has been spotted in both Australia and India, where AstraZeneca’s vaccine is also being dished out. It is also a known rare side effect of flu and HPV jabs.

AstraZeneca’s jab — which is given as a double-dose — has also been heavily linked to deadly blood clots in younger adults.

For that reason, UK drug watchdogs have recommended under-40s, who face a tiny risk of falling seriously ill with Covid, get alternative jabs.

But data is now also emerging that shows Pfizer’s jab — the other main option being administered in the UK — may cause heart inflammation.


Share this:
Scroll to Top